When a CML patient achieves complete cytogenetic response (no detectable Ph) after starting TKI, the approximate equivalent BCR::ABL1 is around 1%IS [5]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.